Suven Life Sciences’ NCE SUVN-D4010 commences phase I trial in US
The trial is being done for cognitive disorders in Alzheimer’s and Schizophrenia
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.